TGF beta 2 and TGF beta 3 isoforms drive fibrotic disease pathogenesis.
Sun, T., Huang, Z., Liang, W.C., Yin, J., Lin, W.Y., Wu, J., Vernes, J.M., Lutman, J., Caplazi, P., Jeet, S., Wong, T., Wong, M., DePianto, D.J., Morshead, K.B., Sun, K.H., Modrusan, Z., Vander Heiden, J.A., Abbas, A.R., Zhang, H., Xu, M., N'Diaye, E.N., Roose-Girma, M., Wolters, P.J., Yadav, R., Sukumaran, S., Ghilardi, N., Corpuz, R., Emson, C., Meng, Y.G., Ramalingam, T.R., Lupardus, P., Brightbill, H.D., Seshasayee, D., Wu, Y., Arron, J.R.(2021) Sci Transl Med 13
- PubMed: 34349032 
- DOI: 10.1126/scitranslmed.abe0407
- Primary Citation of Related Structures:  
6XM2 - PubMed Abstract: 
Transforming growth factor-β (TGFβ) is a key driver of fibrogenesis. Three TGFβ isoforms (TGFβ1, TGFβ2, and TGFβ3) in mammals have distinct functions in embryonic development; however, the postnatal pathological roles and activation mechanisms of TGFβ2 and TGFβ3 have not been well characterized ...